Fábio Rosa highlighted as one of the young 34 promising Scanian personalities of 2020
Rapidus and PwC highlighted Fábio Rosa as one of 34 young promising Scanian personalities and driven entrepreneurs of this year.
News
Asgard Therapeutics highlighted at the Medicon Valley Alliance/ Øresundsinstituttet report
In a new survey published by Øresund Institute and Medicon Valley Alliance, Asgard Therapeutics was highlighted as one of 426 life science companies in Skåne. https://www.oresundsinstituttet.org/life-science-skane/?utm_campaign=unspecified&utm_content=unspecified&utm_medium=email&utm_source=apsis-anp-3
Filipe Pereira awarded with Mats Paulsson Grant 2020
Mats Paulsson Foundations awarded Filipe Pereira, co-founder of Asgard Therapeutics, with a Mats Paulsson Grant 2020. Since 2019, the foundation has focused on grants for academic research projects that in
Filipe Pereira awarded with the KiiLN Postdoctoral Entrepreneurship Award
The KiiLN- Keystone for Incubating Innovation in Life Sciences Network team and Icahn School of Medicine at Mount Sinai awarded Filipe Pereira, co-founder of Asgard Therapeutics, the KiiLN Postdoctoral Entrepreneurship Award. This award
Asgard Therapeutics becomes a SmiLe member
Asgard Therapeutics AB has been admitted to SmiLe Incubator as the next step to move forward on the pre-clinical studies of their lead program TrojanDC. https://news.smileincubator.com/posts/pressreleases/immunotherapy-company-asgard-therapeutics-is
Asgard featured on the Pharma Industry report about ATMPs in Sweden
Advanced Therapies Medical Products (ATMPs) are considered the “drugs of the future”. These are based on gene, cell and tissue products. Sweden has the ambitious goal of becoming a leader
Filipe Pereira, Cristiana Pires and Fábio Rosa, co-founders of Asgard Therapeutics, awarded with the Lund University and Sparbanken Skåne’s prize for future innovations
Together with Sparbanken Skåne, in collaboration with the Sparbanksstiftelsen Finn, Lund University awarded Filipe Pereira, Cristiana Pires and Fábio Rosa the Lund University and Sparbanken Skåne’s prize for future innovations.
Filipe Pereira, co-founder of Asgard Therapeutics, awarded with a BII PreSeed grant
The BioInnovation Institute (BII) awarded Filipe Pereira, co-founder of Asgard Therapeutics, with DKK 3.5M to advance pre-clinical development of dendritic cell reprogramming and define its regulatory roadmap towards the clinic.
Asgard Therapeutics awarded Vinnova’s Innovative Startup Step 2
Swedish start-up company Asgard Therapeutics has been awarded the second step of Vinnova’s Innovative Startup program in order to further develop a new cancer immunotherapy based on dendritic cell reprogramming.
Asgard Therapeutics awarded with Lund University Innovation VFT+ Funds
Asgard was selected to receive Vinnova’s VFT+ funds managed by LU Innovation for verification activities of TrojanDC towards partners, customers and investors.
Fábio Rosa, co-founder of Asgard Therapeutics, selected for Forbes 30 under 30 List – Europe – Science & Healthcare 2020
Fábio Rosa, co-founder of Asgard Therapeutics, was selected by Forbes among 30 brightest young entrepreneurs, innovators and game changers in Science and Healthcare segment. https://www.forbes.com/profile/fabio-rosa/#7376307670f8
Filipe Pereira, co-founder of Asgard Therapeutics, awarded with European Research Council (ERC) Consolidator Grant
The European Research Council (ERC) awarded Filipe Pereira, co-founder of Asgard Therapeutics, with an ERC Consolidator Grant to harness dendritic cell reprogramming towards the development of new patient-specific strategies for
Our project "Turning head and neck cancer into immune cells: preclinical validation and clinical plan of TrojanDC" got funding from @swelife and @medtech4health! Together with @lindstedt_m (@LTHinfo) and Lennart Greiff (@skanesus), we will bring TrojanDC to the patients in need!
Grattis till alla 18 fantastiska projekt som får medel i Swelifes och @medtech4health gemensamma utlysning Samverkansprojekt för bättre hälsa!
https://bit.ly/3fvzNIe
Svensk life science är ju bara bäst! 🧑🔬🧑🏽🔬🧑🏻⚕️✨✨✨✨
Thank you BioInnovation Institute for hosting our pitch today at #Bioseed 2021! It was a great opportunity to present our ambitious aim of revolutionising cancer treatment using cell reprogramming! @bobbysoniDK
More innovative early-stage companies showcasing their 5-minute #Investment pitch at #BioSeed kindly hosted by BioInnovation Institute @Viscgo #STARKLABS #ConnexinTherapeutics #WobbleGenomics @carcinotech #Ciana Therapeutics #PokeAcell @AsgardThx @2NPharma
#LifeSciences
Our CEO @_CristianaPires was selected to present Asgard's Business case at the EIC Investor Day Women in Tech 2.0 on the 17th of December!
Don't miss this opportunity to know more about @AsgardThx and register here: https://community-smei.easme-web.eu/articles/events-eic-investor-day-women-tech-20-bridging-gap-during-covid-19
#WomenInSTEM #cancerimmunotherapy
We are happy to share that Asgard's co-founder Filipe Pereira (@CellReproLab) received the Mats Paulsson Grant 2020 to further develop our lead program #TrojanDC!
#grants #innovation #cancerimmunotherapy #cellreprogramming
More info: https://www.mediconvillage.se/en/node/2306?utm_campaign=unspecified&utm_content=unspecified&utm_medium=email&utm_source=apsis-anp-3
Congrats to @AsgardThx and Filipe Pereira, winner of the 2020 @IcahnMountSinai @KiiLNYC Postdoc Entrepreneurship award! Thanks @MountSinaiLiver @GradSchoolSinai @MountSinaiAlum for support. #SINAInnovations @labknight @ilse_daehn @GabriNyc @YZorina @Merina_V https://twitter.com/labknight/status/1336424228426539019
Congrats @AsgardThx and Filipe Pereira @CellReproLab for winning the 2020 @KiiLNYC Postdoc Entrepreneurship Award presented today at the @IcahnMountSinai Innovation Awards! cc. @MountSinai_IP @Merina_V @YZorina @ilse_daehn @GabriNyc